During the past decade, The Female/Male Health Centres conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Female/Male Health Centres" are "Prostate Cancer" (3 trials) and "Prostate Cancer Metastatic" (1 trials). Many other conditions were trialed in "The Female/Male Health Centres" in a lesser frequency.

Most popular intervention types in "The Female/Male Health Centres" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (2 trials), "Degarelix 160 mg / Degarelix 160 mg" (1 trials), "Degarelix 80 mg / Degarelix 80 mg" (1 trials), "GM-CSF" (1 trials) and "GM-CSF Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Female/Male Health Centres" are 4 trials for "Male" genders.

Currently, there are NaN active trials in "The Female/Male Health Centres". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Female/Male Health Centres, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Female/Male Health Centres, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".